Elisabetta Mandosi

Chronic Inhibition of cGMP Phosphodiesterase 5A Improves Diabetic Cardiomyopathy

Elisa Giannetta, Andrea M. Isidori, Nicola Galea et al. · Circulation · 2012 · 189 citations · Full text

Medicine, Cardiology, Pharmacology +17

Short-term effects of glucagon-like peptide 1 (GLP-1) receptor agonists on fat distribution in patients with type 2 diabetes mellitus: an ultrasonography study

Susanna Morano, Elisabetta Romagnoli, Tiziana Filardi et al. · Acta Diabetologica · 2015 · 106 citations · Full text

Medicine, Endocrinology, Internal Medicine +17

Endothelial dysfunction and oxidative stress in type 1 and type 2 diabetic patients without clinical macrovascular complications

Giancarlo De Mattia, Maria Cristina Bravi, O. Laurenti et al. · Diabetes Research and Clinical Practice · 2008 · 54 citations

Veterinary Medicine, Endocrinology, Internal Medicine +16

Poor Glycemic Control Is an Independent Risk Factor for Low HDL Cholesterol in Patients With Type 2 Diabetes

Alessandra Gatti, Marianna Maranghi, Simonetta Bacci et al. · Diabetes Care · 2009 · 53 citations · Full text

Medicine, Endocrinology, Diabetology +16

Endothelial dysfunction markers as a therapeutic target for Sildenafil treatment and effects on metabolic control in type 2 diabetes

Elisabetta Mandosi, Elisa Giannetta, Tiziana Filardi et al. · Expert Opinion on Therapeutic Targets · 2015 · 50 citations · Full text

Medicine, Endocrinology, Pharmacology +17